UC San Francisco scientists ushered in the era of type 1 diabetes prevention, nearly 40 years ago. Now, they’re working to solve the biggest challenges standing between patients and functional cures ...

A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system ...

There is substantial interest in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in type 1 diabetes, but data on the long-term clinical outcomes are lacking. Using national electronic ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD). The ...

Grayson Visco, 14, of Hudsonville, was at high risk for developing type 1 diabetes. His father has the autoimmune disease, and that made Grayson a good candidate for screening. Testing showed he had ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Tzield to delay progression to stage 3 type 1 diabetes in children aged 1 to 7 years. In an ...